REFERENCES:
  1. Alexandrov LB, Kim J, Haradhvala NJ, Huang MN, Tian Ng AW, Wu Y et al. (2020) The repertoire of mutational signatures in human cancer.Nature, 578(7793):94-101.
  2. Benkerroum N. (2020) Aflatoxins: producing-molds, structure, health issues and incidence in Southeast Asian and sub-saharan African countries. Int J Environ Res Public Health, 17(4).
  3. Brown KL, Voehler MW, Magee SM, Harris CM, Harris TM, Stone MP. (2009) Structural perturbations induced by the α-anomer of the aflatoxin B1 formamidopyrimidine adduct in duplex and single-strand DNA. J Am Chem Soc, 131(44):16096-16107.
  4. Chawanthayatham S, Valentine CC, 3rd, Fedeles BI, Fox EJ, Loeb LA, Levine SS et al. (2017) Mutational spectra of aflatoxin B1 in vivo establish biomarkers of exposure for human hepatocellular carcinoma. Proc Natl Acad Sci U S A,114(15):E3101-E3109.
  5. Coskun E, Jaruga P, Vartanian V, Erdem O, Egner PA, Groopman JD et al. (2019) Aflatoxin-guanine DNA adducts and oxidatively-induced DNA damage in aflatoxin-treated mice in vivo as measured by liquid chromatography-tandem mass spectrometry with isotope-dilution.Chem Res Toxicol, 32:80-89.
  6. Croy RG, Wogan GN. (1981) Temporal patterns of covalent DNA adducts in rat liver after single and multiple doses of aflatoxin B1. Cancer Res, 41(1):197-203.
  7. Fedeles BI, Essigmann JM. (2018) Impact of DNA lesion repair, replication and formation on the mutational spectra of environmental carcinogens: Aflatoxin B1 as a case study. DNA Repair (Amst), 71:12-22.
  8. Gehrke TH, Lischke U, Gasteiger KL, Schneider S, Arnold S, Muller HC et al. (2013) Unexpected non-Hoogsteen-based mutagenicity mechanism of FaPy-DNA lesions. Nat Chem Biol, 9(7):455-461.
  9. Huang MN, Yu W, Teoh WW, Ardin M, Jusakul A, Ng AWT et al. (2017) Genome-scale mutational signatures of aflatoxin in cells, mice, and human tumors. Genome Res, 27(9):1475-1486.
  10. Kensler TW, Roebuck BD, Wogan GN, Groopman JD. (2011) Aflatoxin: a 50-year odyssey of mechanistic and translational toxicology.Toxicol Sci, 120 Suppl 1:S28-48.
  11. Kobets T, Smith BPC, Williams GM. (2022) Food-borne chemical carcinogens and the evidence for human cancer risk. Foods,11(18).
  12. Kucab JE, Zou X, Morganella S, Joel M, Nanda AS, Nagy E et al. (2019) A compendium of mutational signatures of environmental agents.Cell, 177(4):821-836 e816.
  13. Li L, Brown KL, Ma R, Stone MP. (2015) DNA sequence modulates geometrical isomerism of the trans -8,9- dihydro-8-(2,6-diamino-4-oxo-3,4-dihydropyrimid-5-yl-formamido)- 9-hydroxy aflatoxin B1 adduct. Chem Res Toxicol, 28(2):225-237.
  14. Lin YC, Li L, Makarova AV, Burgers PM, Stone MP, Lloyd RS. (2014) Molecular basis of aflatoxin-induced mutagenesis-role of the aflatoxin B1-formamidopyrimidine adduct. Carcinogenesis,35(7):1461-1468.
  15. Lin YC, Owen N, Minko IG, Lange SS, Tomida J, Li L et al. (2016) DNA polymerase ζ limits chromosomal damage and promotes cell survival following aflatoxin exposure. Proc Natl Acad Sci U S A,113(48):13774-13779.
  16. McCullough AK, Lloyd RS. (2019) Mechanisms underlying aflatoxin-associated mutagenesis - Implications in carcinogenesis.DNA Repair (Amst), 77:76-86.
  17. Minko IG, Rizzo CJ, Lloyd RS. (2017) Mutagenic potential of nitrogen mustard-induced formamidopyrimidine DNA adduct: Contribution of the non-canonical α-anomer. J Biol Chem, 292(46):18790-18799.
  18. Smela ME, Hamm ML, Henderson PT, Harris CM, Harris TM, Essigmann JM. (2002) The aflatoxin B1 formamidopyrimidine adduct plays a major role in causing the types of mutations observed in human hepatocellular carcinoma. Proc Natl Acad Sci U S A,99(10):6655-6660.
  19. Strauss BS. (2002) The ”A” rule revisited: polymerases as determinants of mutational specificity. DNA Repair (Amst), 1(2):125-135.
  20. Tomar R, Minko IG, Kellum AH, Jr., Voehler MW, Stone MP, McCullough AK et al. (2021) DNA sequence modulates the efficiency of NEIL1-catalyzed excision of the aflatoxin B1-induced formamidopyrimidine guanine adduct. Chem Res Toxicol,34(3):901-911.
  21. Vartanian V, Minko IG, Chawanthayatham S, Egner PA, Lin YC, Earley LF et al. (2017) NEIL1 protects against aflatoxin-induced hepatocellular carcinoma in mice. Proc Natl Acad Sci U S A, 114(16):4207-4212.
  22. Volkova NV, Meier B, Gonzalez-Huici V, Bertolini S, Gonzalez S, Vohringer H et al. (2020) Mutational signatures are jointly shaped by DNA damage and repair. Nat Commun, 11(1):2169.
  23. Zhang W, He H, Zang M, Wu Q, Zhao H, Lu LL et al. (2017) Genetic features of aflatoxin-associated hepatocellular carcinoma.Gastroenterology, 153(1):249-262 e242.